Wealth Awesome
TSX open
Loading markets…
Interactive Brokers: IBKR clients beat the S&P 500 in 2025 — 19.20% average client return vs 17.9% for the index, net of commissions and charges.

Insider · fund or company

Olymbec Investments Inc.

Olymbec Investments Inc. has reported about $43.6M in shares of Cannara Biotech Inc on SEDI, Canada's insider filing system. That is #205 among the insiders we track.

Holdings as of November 17, 2026 · 10% holder

Disclosed holdings

$43.6M

Companies

1

Buys / sells (12 months)

1 / 0

Net bought (12 months)

+$97K

About these filings

Directors, officers and large shareholders of Canadian-listed companies must report their trades on SEDI, usually within five days. A filing shows what they did with their own shares, not why: people buy and sell for many reasons, including taxes, diversification and option exercises. The data here is a record of those filings and what the stocks did afterwards, not a recommendation.

Follow Olymbec Investments Inc.

Get an email when they file a new trade on SEDI. Free, with the Wealth Awesome newsletter.

Holdings by company

Latest balance reported on SEDI for each company (direct and through holding companies), valued at the latest close.

CompanyRoleSharesValueLast filing
Cannara Biotech IncLOVE.V · all insiders10% holder23,842,920$43.6M2026-07-29

Track record after buying

Every open-market buy since 2016, and what the stock did 3, 6 and 12 months later (adjusted closes; same-day buys of one stock count once; each return capped at +300%). Ranked #90 on the insider track record.

Buys

30

Avg after 3 months

+0.4%

Avg after 6 months

+3.8%

Avg after 12 months

+50.8%

Up after 1 year

67% of 27

DateCompanyBought3 mo6 mo12 mo
2026-07-29Cannara Biotech IncLOVE.V$97Knot yetnot yetnot yet
2025-05-06Cannara Biotech IncLOVE.V$350K+39.9%+18.1%not yet
2025-05-01Cannara Biotech IncLOVE.V$138K+22.2%+15.3%not yet
2025-01-31Cannara Biotech IncLOVE.V$14K+30.3%+72.5%+57.8%
2024-11-29Cannara Biotech IncLOVE.V$15K+74.7%+59.5%+107.6%
2024-11-28Cannara Biotech IncLOVE.V$15K+84.0%+69.3%+125.3%
2024-08-21Cannara Biotech IncLOVE.V$92K−13.0%+55.8%+142.9%
2024-08-15Cannara Biotech IncLOVE.V$44K−14.3%+80.0%+172.9%
2024-07-26Cannara Biotech IncLOVE.V$30K+4.7%+32.8%+179.7%
2024-05-21Cannara Biotech IncLOVE.V$5K−18.5%−27.2%+56.8%
2024-05-17Cannara Biotech IncLOVE.V$8K−16.0%−24.7%+63.0%
2024-05-16Cannara Biotech IncLOVE.V$8K−12.5%−25.0%+63.8%
2024-05-15Cannara Biotech IncLOVE.V$5K−18.2%−18.2%+66.2%
2024-05-14Cannara Biotech IncLOVE.V$5K−22.1%−22.1%+64.9%
2024-05-13Cannara Biotech IncLOVE.V$5K−19.8%−23.5%+65.4%
2024-05-10Cannara Biotech IncLOVE.V$16K−11.5%−15.4%+70.5%
2024-05-09Cannara Biotech IncLOVE.V$4K−11.5%−12.8%+69.2%
2024-05-08Cannara Biotech IncLOVE.V$4K−16.2%−12.2%+81.1%
2024-05-07Cannara Biotech IncLOVE.V$5K−18.4%−1.3%+71.1%
2024-02-29Cannara Biotech IncLOVE.V$50K−24.5%−26.5%+40.8%
2024-02-27Cannara Biotech IncLOVE.V$48K−27.0%−36.0%+29.0%
2023-05-31Cannara Biotech IncLOVE.V$74K+0.0%−12.6%−22.1%
2023-05-30Cannara Biotech IncLOVE.V$78K+0.0%−7.4%−22.1%
2023-05-29Cannara Biotech IncLOVE.V$11K+0.0%−7.4%−23.2%
2023-05-26Cannara Biotech IncLOVE.V$425+0.0%−5.3%−21.1%

Showing the latest 25 of 30 buys.

Recent insider filings

DateCompanyTypeSharesPriceBalance after
2026-07-29Cannara Biotech IncCommon SharesBuy50,000$1.9323,842,920
2025-10-01Cannara Biotech IncConvertible DebenturesConversion or exchange———
2025-10-01Cannara Biotech IncCommon SharesConversion or exchange3,462,763$1.8023,792,920
2025-05-06Cannara Biotech IncCommon SharesBuy250,000$1.4020,330,157
2025-05-01Cannara Biotech IncCommon SharesBuy97,900$1.4120,080,157
2025-01-31Cannara Biotech IncCommon SharesBuy12,500$1.0819,982,257
2024-11-29Cannara Biotech IncCommon SharesBuy19,000$0.77119,969,757
2024-11-28Cannara Biotech IncCommon SharesBuy21,000$0.73719,950,757
2024-08-21Cannara Biotech IncCommon SharesBuy120,500$0.76419,929,757
2024-08-15Cannara Biotech IncCommon SharesBuy63,500$0.68819,809,257
2024-07-26Cannara Biotech IncCommon SharesBuy48,000$0.62619,745,757
2024-05-21Cannara Biotech IncCommon SharesBuy6,000$0.82019,697,757
2024-05-17Cannara Biotech IncCommon SharesBuy10,000$0.82119,691,757
2024-05-16Cannara Biotech IncCommon SharesBuy10,000$0.80119,681,757
2024-05-15Cannara Biotech IncCommon SharesBuy6,000$0.79019,671,757
2024-05-14Cannara Biotech IncCommon SharesBuy6,000$0.77919,665,757
2024-05-13Cannara Biotech IncCommon SharesBuy6,000$0.79819,659,757
2024-05-10Cannara Biotech IncCommon SharesBuy21,000$0.78119,653,757
2024-05-09Cannara Biotech IncCommon SharesBuy6,000$0.73019,632,757
2024-05-08Cannara Biotech IncCommon SharesBuy6,000$0.74719,626,757
2024-05-07Cannara Biotech IncCommon SharesBuy6,000$0.76019,620,757
2024-02-29Cannara Biotech IncCommon SharesBuy50,000$1.00019,614,757
2024-02-27Cannara Biotech IncCommon SharesBuy50,000$0.95419,564,757
2023-05-31Cannara Biotech IncCommon SharesBuy66,000$1.1319,514,757
2023-05-30Cannara Biotech IncCommon SharesBuy61,000$1.0019,448,757
2023-05-30Cannara Biotech IncCommon SharesBuy2,000$0.99019,387,757
2023-05-30Cannara Biotech IncCommon SharesBuy10,000$0.98019,385,757
2023-05-30Cannara Biotech IncCommon SharesBuy500$0.96019,375,757
2023-05-30Cannara Biotech IncCommon SharesBuy5,000$0.95019,375,257
2023-05-30Cannara Biotech IncCommon SharesBuy500$0.93019,370,257
2023-05-29Cannara Biotech IncCommon SharesBuy2,000$0.94019,369,757
2023-05-29Cannara Biotech IncCommon SharesBuy2,500$0.92019,367,757
2023-05-29Cannara Biotech IncCommon SharesBuy7,500$0.90019,365,257
2023-05-26Cannara Biotech IncCommon SharesBuy500$0.85019,357,757
2023-05-25Cannara Biotech IncCommon SharesBuy12,500$0.85019,357,257
2023-05-24Cannara Biotech IncCommon SharesBuy2,000$0.85019,344,757
2023-05-19Cannara Biotech IncCommon SharesBuy6,000$0.88019,342,757
2023-05-18Cannara Biotech IncCommon SharesBuy6,025$0.85019,336,757
2023-02-13Cannara Biotech IncCommon SharesBuy10,300$0.99019,330,732
2023-02-13Cannara Biotech IncCommon SharesStock split or consolidation-173,883,891—19,320,432

Free with a Wealth Awesome account

Keep analysing Olymbec Investments Inc., free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.

How we count it: for each company we take the latest share balance Olymbec Investments Inc. reported on SEDI for common-type shares (held directly or through holding companies) and value it at the latest close. Options, warrants and share units are left out, and so are balances with no filing in the last three years (insiders stop reporting when they leave the role). This is not a net worth figure: it covers only Canadian-listed shares reported on SEDI, and balances can lag until the next filing.

Canada's biggest insider shareholders · Latest insider trades

Awesome Portfolio™

Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →